Compounds > paroxetine

Page last updated: 2024-08-23

paroxetine and Abstinence Syndrome, Neonatal

paroxetine has been researched along with Abstinence Syndrome, Neonatal in 13 studies

Research

Studies (13)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	12 (92.31)	29.6817
2010's	1 (7.69)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dilillo, D; Penagini, F; Pogliani, L; Schneider, L; Zuccotti, GV	1
Costei, AM; Ho, T; Ito, S; Koren, G; Kozer, E	1
Coombs, RC; Isbister, GK; Jaiswal, S	1
Clarke, P; Haddad, PM; Pal, BR; Sridhiran, S; Wieck, A	1
Hashimoto, K	1
Knoppert, DC; Nimkar, R; Principi, T; Yuen, D	1
Stiskal, JA	1
Ahmed, M; Parameshwaran, A; Swamy, P	1
Miller, KM; Murray, KL; Pearson, DL	1
Bosschaart, AN; Kok-Van Rooij, GW; Nijhuis, IJ	1
Ho, T; Ito, S; Koren, G; Kulin, N; Stiskal, JA	1
Clancy, C; Dawson, A; Isbister, GK; Prior, FH; Smith, AJ; Whyte, IM	1

Other Studies

13 other study(ies) available for paroxetine and Abstinence Syndrome, Neonatal

Article	Year
Paroxetine and neonatal withdrawal syndrome. BMJ case reports, 2010, Apr-29, Volume: 2010 Topics: Adult; Antidepressive Agents, Second-Generation; Depression; Female; Humans; Infant, Newborn; Male; Neonatal Abstinence Syndrome; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects	2010
Perinatal outcome following third trimester exposure to paroxetine. Archives of pediatrics & adolescent medicine, 2002, Volume: 156, Issue:11 Topics: Adult; Case-Control Studies; Female; Humans; Hypoglycemia; Infant, Newborn; Jaundice; Maternal-Fetal Exchange; Neonatal Abstinence Syndrome; Paroxetine; Pregnancy; Pregnancy Trimester, Third; Prospective Studies; Respiratory Distress Syndrome, Newborn; Selective Serotonin Reuptake Inhibitors	2002
Paroxetine withdrawal in a neonate with historical and laboratory confirmation. European journal of pediatrics, 2003, Volume: 162, Issue:10 Topics: Adult; Antidepressive Agents, Second-Generation; Female; Humans; Hydroxyindoleacetic Acid; Infant, Newborn; Male; Neonatal Abstinence Syndrome; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects	2003
Neonatal complications after intrauterine exposure to SSRI antidepressants. Prescrire international, 2004, Volume: 13, Issue:71 Topics: Antidepressive Agents; Citalopram; Depression; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; France; Humans; Infant, Newborn; Neonatal Abstinence Syndrome; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Third; Risk; Selective Serotonin Reuptake Inhibitors; Sertraline	2004
Neonatal symptoms following maternal paroxetine treatment: serotonin toxicity or paroxetine discontinuation syndrome? Journal of psychopharmacology (Oxford, England), 2005, Volume: 19, Issue:5 Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Diagnosis, Differential; Female; Humans; Infant, Newborn; Neonatal Abstinence Syndrome; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome	2005
Neonatal signs following exposure to SSRIs. Human psychopharmacology, 2005, Volume: 20, Issue:7 Topics: Adult; Behavior; Female; Humans; Infant, Newborn; Neonatal Abstinence Syndrome; Paroxetine; Pregnancy; Receptors, sigma; Selective Serotonin Reuptake Inhibitors; Sigma-1 Receptor	2005
Paroxetine toxicity in a newborn after in utero exposure: clinical symptoms correlate with serum levels. Therapeutic drug monitoring, 2006, Volume: 28, Issue:1 Topics: Adult; Breast Feeding; Drug Monitoring; Female; Humans; Infant, Newborn; Maternal-Fetal Exchange; Neonatal Abstinence Syndrome; Paroxetine; Pregnancy; Selective Serotonin Reuptake Inhibitors	2006
Defective alleles may not have contributed to adverse effects. Therapeutic drug monitoring, 2006, Volume: 28, Issue:1 Topics: Cytochrome P-450 CYP2D6; Female; Humans; Infant, Newborn; Maternal-Fetal Exchange; Neonatal Abstinence Syndrome; Paroxetine; Pregnancy; Selective Serotonin Reuptake Inhibitors	2006
Neonatal convulsions secondary to paroxetine withdrawal. JPMA. The Journal of the Pakistan Medical Association, 2007, Volume: 57, Issue:3 Topics: Antidepressive Agents, Second-Generation; Depression; Diagnosis, Differential; Epilepsy, Benign Neonatal; Female; Humans; Infant, Newborn; Male; Maternal Exposure; Neonatal Abstinence Syndrome; Paroxetine; Pregnancy; Pregnancy Complications	2007
Neonatal withdrawal syndrome following in utero exposure to paroxetine, clonazepam and olanzapine. Journal of perinatology : official journal of the California Perinatal Association, 2007, Volume: 27, Issue:8 Topics: Antidepressive Agents, Second-Generation; Benzodiazepines; Clonazepam; Humans; Infant, Newborn; Male; Neonatal Abstinence Syndrome; Olanzapine; Paroxetine; Respiratory Insufficiency; Serotonin Syndrome	2007
Withdrawal reactions of a premature neonate after maternal use of paroxetine. Archives of disease in childhood. Fetal and neonatal edition, 2001, Volume: 84, Issue:1 Topics: Antidepressive Agents, Second-Generation; Female; Humans; Infant, Newborn; Infant, Premature; Neonatal Abstinence Syndrome; Paroxetine; Pregnancy; Prenatal Exposure Delayed Effects; Remission, Spontaneous	2001
Neonatal paroxetine withdrawal syndrome. Archives of disease in childhood. Fetal and neonatal edition, 2001, Volume: 84, Issue:2 Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Drug Synergism; Enterocolitis, Necrotizing; Female; Histamine H1 Antagonists; Humans; Infant, Newborn; Male; Neonatal Abstinence Syndrome; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists	2001
Neonatal paroxetine withdrawal syndrome or actually serotonin syndrome? Archives of disease in childhood. Fetal and neonatal edition, 2001, Volume: 85, Issue:2 Topics: Antidepressive Agents, Second-Generation; Humans; Infant, Newborn; Neonatal Abstinence Syndrome; Paroxetine; Selective Serotonin Reuptake Inhibitors; Terminology as Topic	2001